Skip to content

Leuprolide studies: 131 papers with results

Page 2 of 3

Leuprolide has 1,829 linked papers. PepBank read up to 120 of the most-cited studies that gave it to people, up to 20 other studies, and the main trials.

  1. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas.

    Stovall TG · American journal of obstetrics and gynecology · 1991

    Randomized controlled trial · 4 results

  2. Safety, side effects and patient acceptance of the luteinizing hormone releasing hormone agonist leuprolide in treatment of benign prostatic hyperplasia.

    Eri LM · The Journal of urology · 1994

    Randomized controlled trial · 11 results

  3. Endocrinological and clinical evaluation of two depot formulations of leuprolide acetate in pre- and perimenopausal breast cancer patients.

    Boccardo F · Cancer chemotherapy and pharmacology · 1999

    Randomized controlled trial · 6 results

  4. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue.

    Ferreira RA · Contraception · 2010

    Randomized controlled trial · 6 results

  5. Comparison of LH-RH analogue 1-month depot and 3-month depot by their hormone levels and pharmacokinetic profile in patients with advanced prostate cancer.

    Tunn UW · Urologia internationalis · 1998

    Randomized controlled trial · 18 results

  6. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women.

    Watanabe Y · Fertility and sterility · 1992

    Randomized controlled trial · 8 results

  7. Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study. Gestrinone Italian Study Group.

    Fertility and sterility · 1996

    Randomized controlled trial · 5 results

  8. Acute Testosterone Deficiency Alters Adipose Tissue Fatty Acid Storage.

    Santosa S · The Journal of clinical endocrinology and metabolism · 2017

    Randomized controlled trial · 1 result

  9. Comparison of leuprolide and diethylstilbestrol for stage D2 adenocarcinoma of prostate.

    Sharifi R · Urology · 1985

    Randomized controlled trial · 8 results

  10. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.

    Rein MS · Fertility and sterility · 1990

    Randomized controlled trial · 4 results

  11. Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis.

    Filicori M · Fertility and sterility · 1996

    Randomized controlled trial · 1 result

  12. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial.

    Mericq MV · The Journal of clinical endocrinology and metabolism · 2000

    Randomized controlled trial · 2 results

  13. The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study.

    Reinsch RC · American journal of obstetrics and gynecology · 1994

    Randomized controlled trial · 4 results

  14. Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin.

    Dawood MY · Fertility and sterility · 1995

    Randomized controlled trial · 5 results

  15. Single-dose pharmacokinetics of leuprolide in humans following intravenous and subcutaneous administration.

    Sennello LT · Journal of pharmaceutical sciences · 1986

    Randomized controlled trial · 10 results

  16. Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes.

    Fryburg DA · The Journal of clinical endocrinology and metabolism · 1997

    Randomized controlled trial · 10 results

  17. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women.

    Gelety TJ · Fertility and sterility · 1995

    Randomized controlled trial · 11 results

  18. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy.

    Banno H · Annals of neurology · 2009

    Randomized controlled trial · 5 results

  19. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain.

    Crosignani PG · Human reproduction (Oxford, England) · 2006

    Randomized controlled trial · 6 results

  20. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.

    Freeman EW · Psychopharmacology bulletin · 1997

    Randomized controlled trial · 7 results

  21. Cardiovascular safety of degarelix: results from a 12-month, comparative, randomized, open label, parallel group phase III trial in patients with prostate cancer.

    Smith MR · The Journal of urology · 2010

    Randomized controlled trial · 10 results

  22. The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome.

    Dodson WC · The Journal of clinical endocrinology and metabolism · 1987

    Randomized controlled trial · 5 results

  23. Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease: a double-blind, placebo-controlled, randomized study.

    Mathias JR · Digestive diseases and sciences · 1998

    Randomized controlled trial · 9 results

  24. Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction.

    Sauer MV · Reproductive biomedicine online · 2004

    Randomized controlled trial · 2 results

  25. Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome.

    Palomba S · Fertility and sterility · 2005

    Randomized controlled trial · 1 result

  26. Clinical characteristics of ovulation induction with human menopausal gonadotropins with and without leuprolide acetate in polycystic ovary syndrome.

    Dodson WC · Fertility and sterility · 1989

    Randomized controlled trial · 3 results

  27. Profound luteinizing hormone suppression after stopping the gonadotropin-releasing hormone-agonist leuprolide acetate.

    Sungurtekin U · Fertility and sterility · 1995

    Randomized controlled trial · 1 result

  28. Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: a Phase III, open-label, international multicenter study.

    Marberger M · Clinical therapeutics · 2010

    Non-randomized trial · 16 results

  29. Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty.

    Badaru A · The Journal of clinical endocrinology and metabolism · 2006

    Non-randomized trial · 5 results

  30. The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters.

    Yannucci J · The Journal of urology · 2006

    Non-randomized trial · 1 result

  31. Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas.

    Di Lieto A · Journal of the Society for Gynecologic Investigation · 2005

    Non-randomized trial · 5 results

  32. 36-month treatment experience of two doses of leuprolide acetate 3-month depot for children with central precocious puberty.

    Lee PA · The Journal of clinical endocrinology and metabolism · 2014

    Non-randomized trial · 8 results

  33. Effect of French maritime pine bark extract on endometriosis as compared with leuprorelin acetate.

    Kohama T · The Journal of reproductive medicine · 2007

    Non-randomized trial · 4 results

  34. Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group.

    Sharifi R · The Journal of urology · 1990

    Non-randomized trial · 8 results

  35. Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles.

    Peñarrubia J · Human reproduction (Oxford, England) · 1998

    Non-randomized trial · 3 results

  36. A prospective, placebo-controlled study of the luteinizing hormone-releasing hormone agonist leuprolide as treatment for patients with benign prostatic hyperplasia.

    Eri LM · The Journal of urology · 1993

    Non-randomized trial · 11 results

  37. Leuprolide acetate treatment and myoma arterial size.

    Rutgers JL · Obstetrics and gynecology · 1995

    Non-randomized trial · 4 results

  38. Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients.

    Cheng YC · The oncologist · 2012

    Non-randomized trial · 3 results

  39. Effects of the luteinizing hormone-releasing hormone agonist leuprolide on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia.

    Eri LM · The Journal of urology · 1995

    Non-randomized trial · 11 results

  40. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial.

    Brown CS · Obstetrics and gynecology · 1994

    Non-randomized trial · 9 results

  41. A phase II study of leuprolide in advanced/recurrent endometrial cancer.

    Covens A · Gynecologic oncology · 1997

    Non-randomized trial · 5 results

  42. A phase II trial of leuprolide acetate in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group study.

    Miller DS · American journal of clinical oncology · 1992

    Non-randomized trial · 10 results

  43. Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.

    De Falco M · Journal of the Society for Gynecologic Investigation · 2006

    Non-randomized trial · 7 results

  44. Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women.

    Drake MT · The Journal of clinical endocrinology and metabolism · 2010

    Non-randomized trial · 3 results

  45. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.

    Schmidt PJ · The New England journal of medicine · 1998

    Non-randomized trial · 2 results

  46. Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women.

    Filicori M · The Journal of clinical endocrinology and metabolism · 1993

    Non-randomized trial · 11 results

  47. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata.

    Friedman AJ · Fertility and sterility · 1989

    Non-randomized trial · 3 results

  48. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.

    Friedman AJ · Fertility and sterility · 1987

    Non-randomized trial · 6 results

  49. Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: preliminary results.

    Mericq V · Clinical endocrinology · 2009

    Non-randomized trial · 6 results

  50. Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers.

    Meyer BR · Clinical pharmacology and therapeutics · 1988

    Non-randomized trial · 5 results

How PepBank reports evidence